Neuralink’s Blindsight Breakthrough: Giving Sight to the Blind, Including Those Born Without It.
Elon Musk has laid out a bold vision for Neuralink’s next major product. Blindsight streams synthetic visual signals straight into the brain’s visual cortex, bypassing damaged or missing eyes and optic nerves entirely.
Musk put it plainly: “Our next product is Blindsight which will enable those who have total loss of vision including to have lost their eyes or the optic nerve or maybe have never seen or even blind from birth to be able to see again, initially low resolution but ultimately very high resolution and then in multiple wavelengths, so it could be like Geordi LaForge in Star Trek and you can see in radar, you can see in infrared, ultraviolet, superhuman capabilities, cybernetic enhancement essentially.”
This is not science fiction. Neuralink already earned FDA Breakthrough Device designation for Blindsight back in 2024. Human trials for vision restoration are targeted for late 2025 or 2026, building on the company’s progress with its first implants that help paralyzed patients control computers with their thoughts.
Start with restoring basic sight to people who have never seen the world. Scale up to resolution that beats natural human vision. Add capabilities normal eyes could never match. It’s classic American innovation: tackle a devastating disability head-on, then push the limits of what’s possible.
Critics will wring their hands over risks or “enhancement.” Meanwhile, real people trapped in darkness stand to gain independence and a fuller life. Neuralink is moving fast because the need is urgent and the potential is massive. If it delivers even a fraction of what’s promised, this will rank as one of the great medical advances of our time.